Cargando…
Fatigue as Mediator Factor in PTSD-Symptoms after Allogeneic Hematopoietic Stem Cell Transplantation
Background: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) is a valid treatment for hematological oncological or metabolic diseases. Despite its therapeutic efficacy, it is an aggressive treatment that impacts negatively on quality of life (QoL) and may result in Post-Traumatic Stress Dis...
Autores principales: | Di Francesco, Giulia, Cieri, Filippo, Esposito, Roberto, Sciarra, Pierpaola, Ballarini, Valeria, Di Ianni, Mauro, Santarone, Stella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144210/ https://www.ncbi.nlm.nih.gov/pubmed/37109093 http://dx.doi.org/10.3390/jcm12082756 |
Ejemplares similares
-
Novel Approaches to Treatment of Acute Myeloid Leukemia Relapse Post Allogeneic Stem Cell Transplantation
por: Liberatore, Carmine, et al.
Publicado: (2023) -
Function, Adjustment, Quality of Life and Symptoms (FAQS) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Survivors: A Study Protocol
por: Bevans, Margaret F, et al.
Publicado: (2011) -
Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major
por: Santarone, Stella, et al.
Publicado: (2022) -
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE
por: Hale, Gregory A., et al.
Publicado: (2013) -
Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation
por: Du, Wei, et al.
Publicado: (2018)